Impact of Intrapartum Oral Azithromycin on the Acquired Macrolide Resistome of Infants' Nasopharynx: A Randomized Controlled Trial
- PMID: 32445474
- PMCID: PMC7819521
- DOI: 10.1093/cid/ciaa609
Impact of Intrapartum Oral Azithromycin on the Acquired Macrolide Resistome of Infants' Nasopharynx: A Randomized Controlled Trial
Abstract
In a post hoc analysis of samples from an intrapartum azithromycin randomized clinical trial, we found that children whose mothers had been treated with the drug had higher prevalence of macrolide-resistance genes msr(A) and ermC at 28 days but not at 12 months. The 2 genes were positively associated in the nasopharynx.
Clinical trials registration: NCT1800942.
Trial registration: ClinicalTrials.gov NCT01800942.
Keywords: ermC; msr(A); azithromycin; NPS; The Gambia.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
References
-
- Bojang A, Camara B, Jagne Cox I, et al. Long-term impact of oral azithromycin taken by Gambian women during labor on prevalence and antibiotic susceptibility of Streptococcus pneumoniae and Staphylococcus aureus in their infants: follow-up of a randomized clinical trial. Clin Infect Dis 2018; 67:1191–7. - PMC - PubMed
-
- Brown-Jaque M, Calero-Cáceres W, Muniesa M. Transfer of antibiotic-resistance genes via phage-related mobile elements. Plasmid 2015; 79:1–7. - PubMed
-
- Lerminiaux NA, Cameron ADS. Horizontal transfer of antibiotic resistance genes in clinical environments. Can J Microbiol 2019; 65:34–44. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
